179 related articles for article (PubMed ID: 17622242)
1. A novel cell-penetrating peptide, M918, for efficient delivery of proteins and peptide nucleic acids.
El-Andaloussi S; Johansson HJ; Holm T; Langel U
Mol Ther; 2007 Oct; 15(10):1820-6. PubMed ID: 17622242
[TBL] [Abstract][Full Text] [Related]
2. Induction of splice correction by cell-penetrating peptide nucleic acids.
El-Andaloussi S; Johansson HJ; Lundberg P; Langel U
J Gene Med; 2006 Oct; 8(10):1262-73. PubMed ID: 16900561
[TBL] [Abstract][Full Text] [Related]
3. Distinct uptake routes of cell-penetrating peptide conjugates.
Lundin P; Johansson H; Guterstam P; Holm T; Hansen M; Langel U; EL Andaloussi S
Bioconjug Chem; 2008 Dec; 19(12):2535-42. PubMed ID: 19012426
[TBL] [Abstract][Full Text] [Related]
4. Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents.
Abes S; Moulton HM; Clair P; Prevot P; Youngblood DS; Wu RP; Iversen PL; Lebleu B
J Control Release; 2006 Dec; 116(3):304-13. PubMed ID: 17097177
[TBL] [Abstract][Full Text] [Related]
5. Structural requirements for cellular uptake and antisense activity of peptide nucleic acids conjugated with various peptides.
Wolf Y; Pritz S; Abes S; Bienert M; Lebleu B; Oehlke J
Biochemistry; 2006 Dec; 45(50):14944-54. PubMed ID: 17154532
[TBL] [Abstract][Full Text] [Related]
6. Activatable cell penetrating peptide-peptide nucleic acid conjugate via reduction of azobenzene PEG chains.
Lee SH; Moroz E; Castagner B; Leroux JC
J Am Chem Soc; 2014 Sep; 136(37):12868-71. PubMed ID: 25185512
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA).
Bendifallah N; Rasmussen FW; Zachar V; Ebbesen P; Nielsen PE; Koppelhus U
Bioconjug Chem; 2006; 17(3):750-8. PubMed ID: 16704214
[TBL] [Abstract][Full Text] [Related]
8. Enhanced cellular delivery of cell-penetrating peptide-peptide nucleic acid conjugates by photochemical internalization.
Shiraishi T; Nielsen PE
Methods Mol Biol; 2011; 683():391-7. PubMed ID: 21053145
[TBL] [Abstract][Full Text] [Related]
9. Improved cellular uptake of antisense peptide nucleic acids by conjugation to a cell-penetrating peptide and a lipid domain.
Shiraishi T; Nielsen PE
Methods Mol Biol; 2011; 751():209-21. PubMed ID: 21674333
[TBL] [Abstract][Full Text] [Related]
10. M918: A Novel Cell Penetrating Peptide for Effective Delivery of HIV-1 Nef and Hsp20-Nef Proteins into Eukaryotic Cell Lines.
Rostami B; Irani S; Bolhassani A; Cohan RA
Curr HIV Res; 2018; 16(4):280-287. PubMed ID: 30520377
[TBL] [Abstract][Full Text] [Related]
11. Synthetic molecular evolution of hybrid cell penetrating peptides.
Kauffman WB; Guha S; Wimley WC
Nat Commun; 2018 Jul; 9(1):2568. PubMed ID: 29967329
[TBL] [Abstract][Full Text] [Related]
12. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
[TBL] [Abstract][Full Text] [Related]
13. Characterization of cellular internalization pathways for CPP-mediated oligonucleotide delivery.
Guterstam P; Andaloussi SE; Langel U
Methods Mol Biol; 2011; 683():219-30. PubMed ID: 21053133
[TBL] [Abstract][Full Text] [Related]
14. Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide.
Abes S; Turner JJ; Ivanova GD; Owen D; Williams D; Arzumanov A; Clair P; Gait MJ; Lebleu B
Nucleic Acids Res; 2007; 35(13):4495-502. PubMed ID: 17584792
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.
Gautam A; Sharma M; Vir P; Chaudhary K; Kapoor P; Kumar R; Nath SK; Raghava GP
Eur J Pharm Biopharm; 2015 Jan; 89():93-106. PubMed ID: 25459448
[TBL] [Abstract][Full Text] [Related]
16. Assessing the delivery efficacy and internalization route of cell-penetrating peptides.
El Andaloussi S; Guterstam P; Langel U
Nat Protoc; 2007; 2(8):2043-7. PubMed ID: 17703217
[TBL] [Abstract][Full Text] [Related]
17. Cellular internalization kinetics of (luciferin-)cell-penetrating peptide conjugates.
Eiríksdóttir E; Mäger I; Lehto T; El Andaloussi S; Langel U
Bioconjug Chem; 2010 Sep; 21(9):1662-72. PubMed ID: 20684543
[TBL] [Abstract][Full Text] [Related]
18. Lipoplex and peptide-based strategies for the delivery of steric-block oligonucleotides.
Resina S; Abes S; Turner JJ; Prevot P; Travo A; Clair P; Gait MJ; Thierry AR; Lebleu B
Int J Pharm; 2007 Nov; 344(1-2):96-102. PubMed ID: 17600642
[TBL] [Abstract][Full Text] [Related]
19. Assessing the uptake kinetics and internalization mechanisms of cell-penetrating peptides using a quenched fluorescence assay.
Mäger I; Eiríksdóttir E; Langel K; El Andaloussi S; Langel U
Biochim Biophys Acta; 2010 Mar; 1798(3):338-43. PubMed ID: 19909725
[TBL] [Abstract][Full Text] [Related]
20. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
Reissmann S
J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]